Camurus falls short on Q4 revenue and profit, issues weaker 2026 guidance
Camurus AB reported fourth-quarter results that missed analyst expectations on both revenue and profit, citing a SEK93 million one-time inventory repurchase tied to a UK distribution change and currency impacts. Sales of key products Buvidal and Brixadi came in below consensus, Oczyesa’s initial German launch produced limited uptake, and the compan…